Patent · US Active

Method of conferring a protective immune response to norovirus

US10688174B2 · kind B2 · utility

3Cited by
30References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 3, 2019
Grant dateJun 23, 2020
Priority date
Expiry dateJun 3, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.